TABLE 1.
Patient no. | Underlying condition | Presentation | Clinical and laboratory findings
|
|||||
---|---|---|---|---|---|---|---|---|
Positive cultureb | Pathology | Serology | Urine antigen testing (ng/ml) | Serum antigen testing (ng/ml) | Serum antigen EDTA testing (ng/ml) | |||
1 | Unk | CNS | Unk | Unk | Unk | 0.14 | 0.09 | 4.42 |
2 | Unk | CNS | Unk | Unk | EIA IgM Pos, IgG Pos | Neg | Neg | Neg |
3 | Cirrhosis corticosteroid | Pulmonary, fatal | BAL specimen | Unk | EIA IgM Pos, IgG Neg | Neg | Neg | Neg |
4 | Unk | Unk | Unk | Unk | Unk | Not done | 0.09 | 3.28 |
5 | None | Pulmonary, chronic cavitary | BAL specimen | Neg | CF of 16 | Neg | Neg | Neg |
6 | Unk | Disseminated | Ear | Unk | Unk | 3.13 | 3.82 | >8.2 |
7 | Unk | Disseminated, fatal | Unk | Unk | Unk | 3.43 | 8.03 | >8.2 |
8 | Heart transplant | Pulmonary, fungemia, fatal | Blood sample | Not done | EIA IgM Neg, IgG Pos | 3.42 | Neg | 0.07 |
9 | None | Disseminated, bone, soft tissuec | Soft tissue | Unk | Unk | 5.06 | >8.2 | >8.2 |
10 | Unk | Unk | Unk | Unk | Unk | 0.48 | 0.18 | 0.28 |
11 | Unk | Unk | Unk | Unk | Unk | 0.15 | Neg | 0.73 |
12 | Unk | Unk | Unk | Unk | Unk | Not done | Neg | 0.77 |
13 | Metabolic syndrome | Pulmonary | Sputum, BAL specimen | Not done | EIA IgM Pos, IgG Pos, CF of 8 | Neg | Neg | 1.33 |
14 | HIV | Asymptomatic | Not done | Not done | IgM Neg, IgG Pos, CF Neg | Not done | Neg | 0.25 |
15 | Unk | Pulmonary, disseminated | Skin | Skin | EIA IgM Pos, IgG Pos, CF of 256 | 0.80 | Neg | 0.65 |
16 | Unk | Pulmonary, disseminated, bone | Not done | Not done | EIA IgM Neg, IgG Pos, CF of 128 | Neg | Neg | Neg |
17 | Diabetes, hypertension | Pulmonary, disseminated, prostatec | Seminal fluid | Not done | CF of 4 | Neg | Neg | Neg |
18 | None | Disseminated, soft tissue | Not done | Not done | EIA IgM Neg, IgG Pos, IDCF Pos, IDTP Neg, CF of 256, CSF CF Neg | Not done | Neg | 0.29 |
19 | None | Pulmonary, disseminated, bonec | Not done | Not done | CF of 4 | Neg | Neg | 0.20 |
20 | None | Disseminated, fatal | CSF, bone | Not done | CF of 128, CSF CF of 8 | 5.68 | 6.99 | >8.2 |
21 | AIDS | Pulmonary | Not done | Not done | CF of 128 | 0.88 | 0.26 | 0.88 |
22 | AIDS | Pulmonaryd | Not done | Not done | EIA IgM Neg, IgG Pos | Neg | Neg | Neg |
23 | HIV | Pulmonarye | Not done | Not done | EIA IgM Neg, IgG Pos | Neg | Neg | Neg |
24 | AIDS | Pulmonaryf | Not done | Not done | Not done | 0.11 | Neg | Neg |
25 | AIDS | Pulmonary, disseminated, CNS | Not done | Not done | EIA IgM Neg, IgG Pos, CF of 256, CSF CF of 128 | 0.08 | Neg | 0.21 |
26 | HIV | Pulmonary | Not done | Not done | EIA IgM Neg, IgG Pos, CF Neg | Neg | Neg | Neg |
27 | AIDS | Pulmonary | Not done | Not done | CF of 128 | Neg | Neg | 0.66 |
28 | AIDS | Pulmonary, disseminated, lymph nodes | Not done | Not done | EIA IgM Neg, IgG Pos, CF of 2 | Neg | Neg | 0.16 |
Patients with proven coccidioidomycosis, n = 9; patients with probable coccidioidomycosis, n = 19. Abbreviations: CNS, central nervous system; BAL, bronchoalveolar lavage; CSF, cerebrospinal fluid; Neg, negative; Pos, positive; Unk, unknown; CF, reciprocal complement fixation titer; IDCF, immunodiffusion assay for complement-fixing antibody; IDTP, immunodiffusion assay for tube precipitin antibody.
Indication of a specimen type denotes that Coccidioides was isolated from that specimen.
Relapse, culture, sputum, bone, and lymph node samples were positive during initial infection.
Diagnosis of coccidioidomycosis as the cause of lung nodules was uncertain because of melanoma.
Culture proven to be pulmonary coccidioidomycosis 5 years earlier.
Original diagnosis 2 years earlier; presented with presumed pulmonary relapse, which responded to fluconazole.